Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer
This study is ongoing, but not recruiting participants.
Study NCT00054509 Information provided by National Cancer Institute (NCI)
First Received: February 5, 2003 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
docetaxel
adjuvant therapy
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
More general drug interventions related to this trial
Antineoplastic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis
National Cancer Institute (NCI)
Back to top of Main Content